Peckforton Pharmaceuticals sold to Abbey Pharma

Specialist pharmaceuticals company Peckforton has been acquired by Abbey Pharma, in a transaction advised by Clearwater International. The acquisition was supported by a £2m investment from growth capital investor Business Growth Fund (BGF), alongside senior debt funding from RBS.

Find out more...

Prism Medical sells UK subsidiary

Clearwater International has advised Toronto-based Prism Medical Ltd on the sale of its UK subsidiary, through a management buyout backed by LDC. Prism is the market leader in the provision of safe patient handling solutions that enable the mobility

Find out more...

CataCap acquires Handicap-Befordring and Colum-bus

Clearwater International advised on the merger of Handicap-Befordring and Colum-bus (“Handicap-Befordring”) and the concurrent sale to CataCap. Handicap-Befordring is the clear market leader within special care transport services in Denmark and operates 235 buses, which transport handicapped, elderly and

Find out more...

Finnamore sold to GE Healthcare

Clearwater International has advised Finnamore, one of the leading dedicated health and social care consultancies in the UK, on its sale to GE Healthcare (NYSE: GE). The acquisition saw GE Healthcare’s UK consultancy arm, formerly Performance Solutions UK, become

Find out more...
3 of 712345...Last »